CRISPR/Cas9 and HIV1

CRISPR/Cas9 and HIV1 Larry H. Bernstein, MD, FCAP, Curator LPBI Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus Hirotaka Ebina, Naoko Misawa, Yuka Kanemura & Yoshio Koyanagi Scientific Reports 2013; 2510(3) Even though highly active anti-retroviral therapy is able to keep HIV-1 replication under control, the virus can lie in a dormant state within the host genome, known as a … Continue reading CRISPR/Cas9 and HIV1